CL2013001345A1 - Compuestos 3-fenilsulfanilmetil-biciclo[3.1.0]hexano-4-sustituidos, antagonistas del receptor mglur 2/3; composicion farmaceutica que comprende uno de estos compuestos; y composicion farmaceutica que comprende uno de estos compuestos y un inhibidor de la reabsorcion de serotonina, tal como fluoxetina o citalopram. - Google Patents
Compuestos 3-fenilsulfanilmetil-biciclo[3.1.0]hexano-4-sustituidos, antagonistas del receptor mglur 2/3; composicion farmaceutica que comprende uno de estos compuestos; y composicion farmaceutica que comprende uno de estos compuestos y un inhibidor de la reabsorcion de serotonina, tal como fluoxetina o citalopram.Info
- Publication number
- CL2013001345A1 CL2013001345A1 CL2013001345A CL2013001345A CL2013001345A1 CL 2013001345 A1 CL2013001345 A1 CL 2013001345A1 CL 2013001345 A CL2013001345 A CL 2013001345A CL 2013001345 A CL2013001345 A CL 2013001345A CL 2013001345 A1 CL2013001345 A1 CL 2013001345A1
- Authority
- CL
- Chile
- Prior art keywords
- compounds
- pharmaceutical composition
- phenylsulfanylmethyl
- citalopram
- fluoxetine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/18—All rings being cycloaliphatic the ring system containing six carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41512110P | 2010-11-18 | 2010-11-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2013001345A1 true CL2013001345A1 (es) | 2013-11-15 |
Family
ID=45099188
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2013001345A CL2013001345A1 (es) | 2010-11-18 | 2013-05-15 | Compuestos 3-fenilsulfanilmetil-biciclo[3.1.0]hexano-4-sustituidos, antagonistas del receptor mglur 2/3; composicion farmaceutica que comprende uno de estos compuestos; y composicion farmaceutica que comprende uno de estos compuestos y un inhibidor de la reabsorcion de serotonina, tal como fluoxetina o citalopram. |
Country Status (36)
Country | Link |
---|---|
US (1) | US8629169B2 (es) |
EP (1) | EP2640697B1 (es) |
JP (1) | JP5877847B2 (es) |
KR (2) | KR20150140876A (es) |
CN (1) | CN103228625B (es) |
AR (1) | AR083845A1 (es) |
AU (1) | AU2011329076B2 (es) |
BR (1) | BR112013012118A2 (es) |
CA (1) | CA2818116C (es) |
CL (1) | CL2013001345A1 (es) |
CO (1) | CO6761385A2 (es) |
CR (1) | CR20130178A (es) |
DK (1) | DK2640697T3 (es) |
DO (1) | DOP2013000099A (es) |
EA (1) | EA021724B1 (es) |
EC (1) | ECSP13012629A (es) |
ES (1) | ES2650139T3 (es) |
GT (1) | GT201300126A (es) |
HR (1) | HRP20171649T1 (es) |
HU (1) | HUE037457T2 (es) |
IL (1) | IL225843A (es) |
LT (1) | LT2640697T (es) |
MA (1) | MA34663B1 (es) |
MX (1) | MX339973B (es) |
NO (1) | NO2640697T3 (es) |
NZ (1) | NZ609816A (es) |
PE (1) | PE20140997A1 (es) |
PL (1) | PL2640697T3 (es) |
PT (1) | PT2640697T (es) |
RS (1) | RS56535B1 (es) |
SG (1) | SG189959A1 (es) |
SI (1) | SI2640697T1 (es) |
TW (1) | TWI520935B (es) |
UA (1) | UA110039C2 (es) |
WO (1) | WO2012068067A1 (es) |
ZA (1) | ZA201302918B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO2978B1 (en) * | 2009-12-21 | 2016-03-15 | ايلي ليلي اند كومباني | MGLU2 aids |
EP3000814A1 (en) | 2014-09-26 | 2016-03-30 | Domain Therapeutics | Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors |
DK3445743T3 (da) | 2016-04-18 | 2021-10-18 | Taisho Pharmaceutical Co Ltd | Prodrug af aminosyrederivat |
JP2020506895A (ja) | 2017-01-17 | 2020-03-05 | ボード オブ レジェンツ, ザ ユニバーシティ オブ テキサス システムBoard Of Regents, The University Of Texas System | インドールアミン2,3−ジオキシゲナーゼおよび/またはトリプトファンジオキシゲナーゼの阻害剤として有用な化合物 |
US11046649B2 (en) | 2018-07-17 | 2021-06-29 | Board Of Regents, The University Of Texas System | Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0669928B2 (ja) | 1987-10-06 | 1994-09-07 | 宇部興産株式会社 | 光重合性歯科材料 |
JP2589812B2 (ja) | 1989-07-05 | 1997-03-12 | 松下電器産業株式会社 | スチームアイロン |
EA000894B1 (ru) * | 1995-11-16 | 2000-06-26 | Эли Лилли Энд Компани | Замещенные бициклогексанкарбоновые кислоты и их производные в качестве антагонистов рецептора возбуждающих аминокислот, способ их получения и применение |
ZA969485B (en) | 1995-11-16 | 1998-05-12 | Lilly Co Eli | Excitatory amino acid receptor antagonists. |
ZA983930B (en) * | 1997-05-14 | 1999-11-08 | Lilly Co Eli | Excitatory amino acid receptor modulators. |
EP1064256B1 (en) * | 1998-03-17 | 2004-08-04 | Pfizer Products Inc. | Bicyclo [2.2.1] heptanes and related compounds |
GB9815542D0 (en) | 1998-07-17 | 1998-09-16 | Lilly Co Eli | Bicyclohexane derivatives |
CH694053A5 (de) | 1998-09-03 | 2004-06-30 | Hoffmann La Roche | Verfahren zur Herstellung von 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarbonsäure-Derivaten. |
WO2002068380A1 (en) * | 2001-02-22 | 2002-09-06 | Eli Lilly And Company | Synthetic excitatory amino acids |
AU2002359923B2 (en) | 2001-12-27 | 2007-12-20 | Taisho Pharmaceutical Co., Ltd. | 6-fluorobicyclo[3.1.0]hexane derivatives |
PT1517915E (pt) * | 2002-06-11 | 2009-04-09 | Lilly Co Eli | Pró-drogas de amino ácidos de excitação |
NZ580554A (en) * | 2003-06-26 | 2011-01-28 | Taisho Pharmaceutical Co Ltd | 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative |
JP2007063129A (ja) | 2003-06-26 | 2007-03-15 | Taisho Pharmaceut Co Ltd | 2−アミノ−3−アルコキシビシクロ[3.1.0]ヘキサン誘導体 |
WO2005000790A1 (ja) * | 2003-06-26 | 2005-01-06 | Taisho Pharmaceutical Co., Ltd. | 2-アミノビシクロ[3.1.0]ヘキサン-2,6-ジカルボン酸誘導体 |
JO2978B1 (en) * | 2009-12-21 | 2016-03-15 | ايلي ليلي اند كومباني | MGLU2 aids |
-
2011
- 2011-11-11 AR ARP110104219A patent/AR083845A1/es unknown
- 2011-11-11 TW TW100141326A patent/TWI520935B/zh not_active IP Right Cessation
- 2011-11-15 EA EA201390498A patent/EA021724B1/ru not_active IP Right Cessation
- 2011-11-15 RS RS20171082A patent/RS56535B1/sr unknown
- 2011-11-15 HU HUE11791692A patent/HUE037457T2/hu unknown
- 2011-11-15 BR BR112013012118A patent/BR112013012118A2/pt not_active IP Right Cessation
- 2011-11-15 WO PCT/US2011/060730 patent/WO2012068067A1/en active Application Filing
- 2011-11-15 LT LTEP11791692.4T patent/LT2640697T/lt unknown
- 2011-11-15 NO NO11791692A patent/NO2640697T3/no unknown
- 2011-11-15 DK DK11791692.4T patent/DK2640697T3/en active
- 2011-11-15 MX MX2013005622A patent/MX339973B/es active IP Right Grant
- 2011-11-15 SG SG2013030507A patent/SG189959A1/en unknown
- 2011-11-15 KR KR1020157034547A patent/KR20150140876A/ko not_active Application Discontinuation
- 2011-11-15 CN CN201180055263.7A patent/CN103228625B/zh active Active
- 2011-11-15 JP JP2013539938A patent/JP5877847B2/ja active Active
- 2011-11-15 ES ES11791692.4T patent/ES2650139T3/es active Active
- 2011-11-15 AU AU2011329076A patent/AU2011329076B2/en not_active Ceased
- 2011-11-15 KR KR1020137012697A patent/KR20130101094A/ko active IP Right Grant
- 2011-11-15 PT PT117916924T patent/PT2640697T/pt unknown
- 2011-11-15 NZ NZ609816A patent/NZ609816A/en not_active IP Right Cessation
- 2011-11-15 US US13/296,384 patent/US8629169B2/en active Active
- 2011-11-15 PL PL11791692T patent/PL2640697T3/pl unknown
- 2011-11-15 PE PE2013001215A patent/PE20140997A1/es not_active Application Discontinuation
- 2011-11-15 EP EP11791692.4A patent/EP2640697B1/en active Active
- 2011-11-15 UA UAA201305835A patent/UA110039C2/ru unknown
- 2011-11-15 SI SI201131304T patent/SI2640697T1/sl unknown
- 2011-11-15 CA CA2818116A patent/CA2818116C/en active Active
-
2013
- 2013-04-18 IL IL225843A patent/IL225843A/en not_active IP Right Cessation
- 2013-04-22 ZA ZA2013/02918A patent/ZA201302918B/en unknown
- 2013-04-24 CR CR20130178A patent/CR20130178A/es unknown
- 2013-05-08 DO DO2013000099A patent/DOP2013000099A/es unknown
- 2013-05-13 MA MA35898A patent/MA34663B1/fr unknown
- 2013-05-15 GT GT201300126A patent/GT201300126A/es unknown
- 2013-05-15 CL CL2013001345A patent/CL2013001345A1/es unknown
- 2013-05-17 EC ECSP13012629 patent/ECSP13012629A/es unknown
- 2013-05-30 CO CO13133036A patent/CO6761385A2/es unknown
-
2017
- 2017-10-27 HR HRP20171649TT patent/HRP20171649T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SMT201600216B (it) | Ottaidropirrolo[3,4.c]pirroli disostituiti come modulatori del recettore di orexina | |
FR2962442B1 (fr) | Composition stable de 2,3,3,3-tetrafluoropropene | |
FR2962608B1 (fr) | Nouvelles structures de redondance pour convertisseurs statiques | |
BRPI1010772A2 (pt) | composto,e, composição farmacêutica. | |
BR112013001571A2 (pt) | composto, composição farmacêutica, uso e método de prevenção ou tratamento de uma condição associada com a função do receptor gpr40 | |
BR112012004335A2 (pt) | composto, composição farmacêutica, e, uso do composto. | |
PL2431442T3 (pl) | Kompozycja na bazie 1,3,3,3-tetrafluoropropenu | |
BR112013003536A2 (pt) | composição, e utilização de uma composição. | |
CL2013000733A1 (es) | Compuestos derivados de arilalquilimidazol, moduladores selectivos de receptores alfa 2 adrenergicos; y composicion farmaceutica que los comprende. | |
BR112013015602A2 (pt) | nova composição farmacèutica | |
BRPI1010617A2 (pt) | uso de uma composição, composição, uso não médico da composição, e, método para preprar uma composição. | |
JO3154B1 (ar) | عوامل مضادة لـ trpv4 | |
CL2013001345A1 (es) | Compuestos 3-fenilsulfanilmetil-biciclo[3.1.0]hexano-4-sustituidos, antagonistas del receptor mglur 2/3; composicion farmaceutica que comprende uno de estos compuestos; y composicion farmaceutica que comprende uno de estos compuestos y un inhibidor de la reabsorcion de serotonina, tal como fluoxetina o citalopram. | |
DK2493312T3 (da) | Farmaceutiske faststofsammensætninger, der indeholder en integrase- hæmmer | |
JP2012523555A5 (es) | ||
CL2013001315A1 (es) | Composicion que comprende micro-organismo probioticos no replicantes extruidos. | |
BRPI1011460A2 (pt) | Composição desinfetante. | |
BRPI1010073A2 (pt) | composição anticancerígina injetável para administração local contendo hidroxicloquina | |
CL2014001862A1 (es) | Compuestos derivados de morofolinilo sustituido, útiles como inhibidores de mogat-2; composicion farmaceutica que los comprende; uso en el tratamiento de hipertrigliceridemia. | |
FR2958159B1 (fr) | Compostion cosmetique ou pharmaceutique | |
MA32461B1 (fr) | Dronedarone pour la prevention de cardioversion | |
BRPI1014382A2 (pt) | inibidor de reabsorção de serotonina e norepinefrina, seu uso e composição farmacêutica | |
WO2011091410A8 (en) | Trpv4 antagonists | |
HK1162959A1 (en) | Pharmaceutical compositions comprising dronedarone | |
CO6640201A2 (es) | Moduladores de crth2 |